BAFF predicts immunogenicity in older patients with rheumatoid arthritis treated with TNF inhibitors

BAFF predicts immunogenicity in older patients with rheumatoid arthritis treated with TNF inhibitors

Abstract Immunogenicity related to treatment with TNF inhibitors (TNFi) is one of the causes for the decreased attainment of clinical response in patients with rheumatoid arthritis (RA). The B-cell activating factor (BAFF) may be playing a role in the development of immunogenicity. The objective of...

Full description

Bibliographic Details
Main Authors:	Borja Hernández-Breijo, Victoria Navarro-Compán, Chamaida Plasencia-Rodríguez, Ioannis Parodis, Johanna E. Gehin, Ana Martínez-Feito, Marta Novella-Navarro, Araceli Mezcua, David J. Warren, Pilar Nozal, Dora Pascual-Salcedo, Alejandro Balsa
Format:	Article
Language:	English
Published:	Nature Portfolio 2021-06-01
Series:	Scientific Reports
Online Access:	https://doi.org/10.1038/s41598-021-91177-4

Similar Items

Low Serum BAFF Concentration Is Associated with Response to TNF Inhibitors in Seropositive Patients with Rheumatoid Arthritis
by: Borja Hernández-Breijo, et al.
Published: (2022-09-01)

Methotrexate Reduces the Probability of Discontinuation of TNF Inhibitors in Seropositive Patients With Rheumatoid Arthritis. A Real-World Data Analysis
by: Borja Hernández-Breijo, et al.
Published: (2021-06-01)

Association between concomitant csDMARDs and clinical response to TNF inhibitors in overweight patients with axial spondyloarthritis
by: Borja Hernández-Breijo, et al.
Published: (2019-02-01)

Comparison of long-term efficacy between biological agents following tumor necrosis factor inhibitor failure in patients with rheumatoid arthritis: a prospective cohort study
by: Patricia Bogas, et al.
Published: (2021-11-01)

Remission Induced by TNF Inhibitors Plus Methotrexate is Associated With Changes in Peripheral Naïve B Cells in Patients With Rheumatoid Arthritis
by: Borja Hernández-Breijo, et al.
Published: (2021-06-01)

Risk Factors for Developing Rheumatoid Arthritis in Patients With Undifferentiated Arthritis and Inflammatory Arthralgia
by: Marta Novella-Navarro, et al.
Published: (2021-06-01)

Coping with rheumatic stressors (CORS) questionnaire: Spanish translation and cross-cultural adaptation
by: Diego Benavent, et al.
Published: (2023-02-01)

Predicting anti-TNF treatment response in rheumatoid arthritis: An artificial intelligence-driven model using cytokine profile and routine clinical practice parameters
by: Juan Luis Valdivieso Shephard, et al.
Published: (2024-01-01)

Impact of immunogenicity on response to anti-TNF therapy in moderate-to-severe plaque psoriasis: results of the PREDIR study
by: Mariano Ara-Martín, et al.
Published: (2017-10-01)

Clinical predictors of multiple failure to biological therapy in patients with rheumatoid arthritis
by: Marta Novella-Navarro, et al.
Published: (2020-12-01)

Data for the crystal structure of APRIL–BAFF–BAFF heterotrimer
by: Klaus Maskos, et al.
Published: (2016-03-01)

BAFF and BAFF-Receptor in B Cell Selection and Survival
by: Cristian R. Smulski, et al.
Published: (2018-10-01)

Therapeutic drug monitoring of biopharmaceuticals in inflammatory rheumatic and musculoskeletal disease: a systematic literature review informing EULAR points to consider
by: Astrid van Tubergen, et al.
Published: (2022-06-01)

B cell alterations during BAFF inhibition with belimumab in SLEResearch in context
by: Daniel Ramsköld, et al.
Published: (2019-02-01)

Inhibition of Membrane-Bound BAFF by the Anti-BAFF Antibody Belimumab
by: Christine Kowalczyk-Quintas, et al.
Published: (2018-11-01)

BAFF controls neural cell survival through BAFF receptor.
by: Satoru Tada, et al.
Published: (2013-01-01)

Monitoring chronic inflammatory musculoskeletal diseases mixing virtual and face-to-face assessments-Results of the digireuma study.
by: Diego Benavent, et al.
Published: (2022-12-01)

Monitoring chronic inflammatory musculoskeletal diseases mixing virtual and face-to-face assessments—Results of the digireuma study
by: Diego Benavent, et al.
Published: (2022-12-01)

Immune response after SARS-CoV-2 vaccination in patients with inflammatory immune-mediated diseases receiving immunosuppressive treatment
by: Chamaida Plasencia-Rodríguez, et al.
Published: (2023-08-01)

IL-35, TNF-α, BAFF, and VEGF serum levels in patients with different rheumatic diseases
by: Piotr Wojdasiewicz, et al.
Published: (2019-06-01)

deltaBAFF, a splice isoform of BAFF, opposes full-length BAFF activity in vivo in transgenic mouse models.
by: Gavin, A, et al.
Published: (2005)

Immunogenicity of TNF-Inhibitors
by: Sadaf Atiqi, et al.
Published: (2020-02-01)

Sex hormone-dependent and -independent regulation of serum BAFF and TNF in cohorts of transgender and cisgender men and women
by: Christos Tsatsanis, et al.
Published: (2023-02-01)

Association of BAFF and BAFF-R polymorphisms with sarcoidosis in a Greek patient cohort
by: Maria Martinou, et al.
Published: (2022-10-01)

Renal Tissue Expression of BAFF and BAFF Receptors Is Associated with Proliferative Lupus Nephritis
by: Miguel Marín-Rosales, et al.
Published: (2022-12-01)

Development of a Novel BAFF Responsive Cell Line Suitable for Detecting Bioactive BAFF and Neutralizing Antibodies against BAFF-Pathway Inhibiting Therapeutics
by: Jenny Hu, et al.
Published: (2014-02-01)

Crucial role for BAFF-BAFF-R signaling in the survival and maintenance of mature B cells.
by: Melanie Rauch, et al.
Published: (2009-01-01)

The effects of Jieduquyuzishen prescription-treated rat serum on the BAFF/BAFF-R signal pathway.
by: De-Hong Wu, et al.
Published: (2015-01-01)

Expression of BAFF and BAFF-R in follicular lymphoma: correlation with clinicopathologic characteristics and survival outcomes.
by: Ya-Jun Li, et al.
Published: (2012-01-01)

The BAFF-APRIL System in Cancer
by: Md Ashik Ullah, et al.
Published: (2023-03-01)

Expression of TNF-superfamily members BAFF and APRIL in breast cancer: Immunohistochemical study in 52 invasive ductal breast carcinomas
by: Stathopoulos Efstathios N, et al.
Published: (2008-03-01)

Transcriptome analysis of renal ischemia/reperfusion (I/R) injury in BAFF and BAFF-R deficient mice.
by: Tamara Möckel, et al.
Published: (2023-01-01)

Transcriptome analysis of renal ischemia/reperfusion (I/R) injury in BAFF and BAFF-R deficient mice
by: Tamara Möckel, et al.
Published: (2023-01-01)

Overexpression of the Cytokine BAFF and Autoimmunity Risk.
by: Steri, M, et al.
Published: (2017)

Reduced Number of Transitional and Naive B Cells in Addition to Decreased BAFF Levels in Response to the T Cell Independent Immunogen Pneumovax®23.
by: Alena Roth, et al.
Published: (2016-01-01)

Patient and physician assessment in difficult-to-treat rheumatoid arthritis: patterns of subjective perception at early stages of b/tsDMARD treatment
by: Alejandro Balsa, et al.
Published: (2023-07-01)

BAFF 60-mer, and Differential BAFF 60-mer Dissociating Activities in Human Serum, Cord Blood and Cerebrospinal Fluid
by: Mahya Eslami, et al.
Published: (2020-11-01)

Predictive model to identify multiple failure to biological therapy in patients with rheumatoid arthritis
by: Marta Novella-Navarro, et al.
Published: (2022-10-01)

Implementation of a hybrid healthcare model in rheumatic musculoskeletal diseases: 6-months results of the multicenter Digireuma study
by: D. Benavent, et al.
Published: (2023-09-01)

Effect of infliximab dose increase in rheumatoid arthritis at different trough concentrations: a cohort study in clinical practice conditions
by: Chamaida ePlasencia, et al.
Published: (2015-10-01)